Trial Profile
Canadian Pradaxa Acute Stroke Safety Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Oct 2021
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary)
- Indications Ischaemic heart disorders; Stroke
- Focus Therapeutic Use
- Acronyms CPASS
- 24 May 2018 Status changed from recruiting to completed.
- 24 Oct 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Mar 2018.
- 16 Apr 2015 New trial record